Maynard, MA, United States of America

Andrew Magee

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biothera Inc., Pliva D.d.. Active years: 2008-2019.

USPTO Granted Patents = 3 

% Patents Active = 66.7



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Magee

Introduction

Andrew Magee is an accomplished inventor based in Maynard, MA (US). He holds three patents, showcasing his contributions to the field of pharmaceuticals. His work primarily focuses on glucan preparations, which have significant implications for medical applications.

Latest Patents

Magee's latest patents involve the solubilization of particulate β-glucan at elevated pressure and temperature. This innovative method produces soluble β-glucan, which is both safe and economical. The resulting product serves as an improved pharmaceutical agent, highlighting Magee's commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Magee has worked with notable companies such as Biothera Inc. and Pliva D.d. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in pharmaceutical technology.

Collaborations

Some of Magee's coworkers include James Rolke and Render Yang. Their collaborative efforts have likely played a role in the development of his innovative patents.

Conclusion

Andrew Magee's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…